Fig. 3From: High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansineKaplan-Meier PFS curves of HER2-Positive Advanced Breast Cancer Patients With T-DM1 Treatment. a Patients stratified according LDH changing trend. b Patients stratified according dNLR changing trendBack to article page